chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Mouth ulceration, Parosmia, Pyrexia, Tremor
Clinical narrative: feels very weak; shaking; can't eat; strong metal taste , like she was "chewing on stainless steel"; bothered by smell"; the inside of her mouth was covered with blisters; increased heart rate; worse flu she could have"; terrible headache; fever; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel") and PAROSMIA (bothered by smell") in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus, Allergic reaction to analgesics (Allergies include codeine and sulfa drugs.) and Sulfonamide allergy. Concomitant products included ISOPHANE INSULIN (NPH INSULIN) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feels very weak; shaking; can't eat; strong metal taste , like she was "chewing on stainless steel"; bothered by smell"; the inside of her mouth was covered with blisters; increased heart rate; worse flu she could have"; terrible headache; fever; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel") and PAROSMIA (bothered by smell") in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus, Allergic reaction to analgesics (Allergies include codeine and sulfa drugs.) and Sulfonamide allergy. Concomitant products included ISOPHANE INSULIN (NPH INSULIN) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Dry throat, Hypoaesthesia, Paraesthesia
Clinical narrative: dry throat; numbness in her face; needles in her face; This spontaneous case was reported by a consumer and describes the occurrence of DRY THROAT (dry throat), HYPOAESTHESIA (numbness in her face) and PARAESTHESIA (needles in her face) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DRY THROAT (dry throat), HYPOAESTHESIA (numbness in her face) and PARAESTHESIA (needles in her face). At the time of the report, DRY THROAT (dry throat), HYPOAESTHESIA (numbness in her face) and PARAESTHESIA (needles in her face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dizziness in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011A21A) for COVID-19 immunization. Concomitant products included levothyroxine for an unknown indication. On Feb 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 4, 2021, patient experienced dizziness. On Mar 8, 2021, dizziness resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No treatment information provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Tenderness, Vaccination site rash, Vaccination site warmth
Clinical narrative: arm was swollen; arm was tender; hot to touch; she have a rash but not sure if it's because of the vaccine or due to the cold weather; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm was swollen), TENDERNESS (arm was tender), VACCINATION SITE WARMTH (hot to touch) and VACCINATION SITE RASH (she have a rash but not sure if it's because of the vaccine or due to the cold weather) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included PAROXETINE, ETHINYLESTRADIOL, NORGESTREL (ELINEST), VITAMIN D3, CALCIUM, MAGNESIUM and ZINC for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm was swollen), TENDERNESS (arm was tender), VACCINATION SITE WARMTH (hot to touch) and VACCINATION SITE RASH (she have a rash but not sure if it's because of the vaccine or due to the cold weather). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm was swollen), TENDERNESS (arm was tender), VACCINATION SITE WARMTH (hot to touch) and VACCINATION SITE RASH (she have a rash but not sure if it's because of the vaccine or due to the cold weather) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medications included Birth control pills and Multi vitamins.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Dyspnoea, Pyrexia
Clinical narrative: sick to her stomach; shortness of breath; low grade fever of (normal body temp 99.7) temp is 99.4; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.7 (High) 99.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: severe sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (severe sinus infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (severe sinus infection). At the time of the report, SINUSITIS (severe sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications were  not reported. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Myalgia, Nausea
Clinical narrative: Chills; fever; aches; tired; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 011M02A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation on 12-Mar-2021, Obstructive sleep apnea syndrome on 01-Nov-2013, GERD on 12-Mar-2012 and Mixed hyperlipidemia on 12-Mar-2012. Concurrent medical conditions included Drug allergy and Allergy to antibiotic. Concomitant products included DILTIAZEM HYDROCHLORIDE (CARDIZEM [DILTIAZEM HYDROCHLORIDE]) from 2016 to an unknown date and FLECAINIDE from 2016 to an unknown date for Atrial fibrillation, EZETIMIBE (ZETIA) for Cholesterol high, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) from 2016 to an unknown date for GERD, EZETIMIBE from 06-Nov-2020 to an unknown date for Hyperlipidemia, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 04-Feb-2021 at 10:25 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021 at 9:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 08-Mar-2021, CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 101.3 (High) 101.3 degree F.         The patient's height and weight were reported as "64" and "140" respectively. The fever never crossed 101F. The symptoms lasted for 6-8 hours.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; fever; aches; tired; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 011M02A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation on 12-Mar-2021, Obstructive sleep apnea syndrome on 01-Nov-2013, GERD on 12-Mar-2012 and Mixed hyperlipidemia on 12-Mar-2012. Concurrent medical conditions included Drug allergy and Allergy to antibiotic. Concomitant products included DILTIAZEM HYDROCHLORIDE (CARDIZEM [DILTIAZEM HYDROCHLORIDE]) from 2016 to an unknown date and FLECAINIDE from 2016 to an unknown date for Atrial fibrillation, EZETIMIBE (ZETIA) for Cholesterol high, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) from 2016 to an unknown date for GERD, EZETIMIBE from 06-Nov-2020 to an unknown date for Hyperlipidemia, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 04-Feb-2021 at 10:25 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021 at 9:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 08-Mar-2021, CHILLS (Chills), PYREXIA (fever), MYALGIA (aches), FATIGUE (tired) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 101.3 (High) 101.3 degree F.         The patient's height and weight were reported as "64" and "140" respectively. The fever never crossed 101F. The symptoms lasted for 6-8 hours.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy
Clinical narrative: This spontaneous pregnancy case reported by a consumer, describes the occurrence of pregnancy in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 003A21A) for an unknown indication. The patient's past medical history included asthma, migraine and hypothyroidism. Concomitant products included levothyroxine. On Mar 6, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. The patient's last menstrual cycle was on Jan 10, 2021 and estimated date of delivery was Oct 17, 2021. On Feb 18, 2021, patient experienced pregnancy. The patient received mRNA-1273 (Moderna COVID-19 vaccine) beginning around the seventh week of the pregnancy. At the time of the report, pregnancy resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Treatment medication taken by patient not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Photophobia
Clinical narrative: sensitivity to light; headache; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (sensitivity to light), HEADACHE (headache) and NAUSEA (nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and un) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PHOTOPHOBIA (sensitivity to light), HEADACHE (headache) and NAUSEA (nausea). On 08-Mar-2021, PHOTOPHOBIA (sensitivity to light), HEADACHE (headache) and NAUSEA (nausea) had resolved.            No relevant concomitant medications reported.  No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Faeces soft
Clinical narrative: Feeling gassy; Having soft stool; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (Feeling gassy) and FAECES SOFT (Having soft stool) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 003B21A) for COVID-19 vaccination.     The patient's past medical history included Osteo arthritis knees on 01-Oct-2014, Valvular heart disease NOS (sulfa drugs) on 23-Jun-2011, Hypertension since 11-Nov-2019 and Obstructive sleep apnea syndrome on 21-Feb-2019. Concurrent medical conditions included Penicillin allergy and Drug allergy (Sulfa drugs). Concomitant products included CENTRUM SILVER +50 from 11-Nov-2019 to an unknown date, BIOTIN from 11-Nov-2019 to an unknown date, CURCUMA LONGA RHIZOME, PIPER NIGRUM FRUIT (TURMERIC +) from 11-Nov-2019 to an unknown date, AMLODIPINE BESILATE, ATORVASTATIN CALCIUM (AMLODIPINE + ATORVASTATIN) from 11-Nov-2019 to an unknown date and ROSUVASTATIN from 11-Nov-2019 to an unknown date for an unknown indication.   On 03-Mar-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 04-Mar-2021, the patient experienced ABDOMINAL DISTENSION (Feeling gassy) and FAECES SOFT (Having soft stool). On 18-Apr-2021, ABDOMINAL DISTENSION (Feeling gassy) had resolved. On 20-Apr-2021, FAECES SOFT (Having soft stool) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.         Treatment Medication for gas included.   Reporter did not allow further contact   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: ADR FUP added, reporter's demographics was added, patient's medical history was added, concomitant medications was added, event outcome was updated
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: her arm started to itch again. It was slightly red, hot, and itchy.; Arm started to itch again; her arm started to itch again. It was slightly red, hot, and itchy.; she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again). On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.). On 03-Mar-2021, VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again) had resolved. At the time of the report, VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Dry barking cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry barking cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced COUGH (Dry barking cough). At the time of the report, COUGH (Dry barking cough) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of disturbance in attention (husband couldn't get wife's attention) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included cancer. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 5, 2021, patient experienced disturbance in attention (husband couldn't get wife's attention). At the time of the report, disturbance in attention (husband couldn't get wife's attention): unresolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Diarrhoea, Ear pain
Clinical narrative: Backache; Sweating; Diarrhea once; Pain in ears; Chills; Thrown up once; Joint Pain; Headache; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears) and CHILLS (Chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears), CHILLS (Chills), VOMITING (Thrown up once), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and FATIGUE (Exhausted). At the time of the report, BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears), CHILLS (Chills), VOMITING (Thrown up once), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and FATIGUE (Exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Vomiting
Clinical narrative: Backache; Sweating; Diarrhea once; Pain in ears; Chills; Thrown up once; Joint Pain; Headache; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears) and CHILLS (Chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears), CHILLS (Chills), VOMITING (Thrown up once), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and FATIGUE (Exhausted). At the time of the report, BACK PAIN (Backache), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea once), EAR PAIN (Pain in ears), CHILLS (Chills), VOMITING (Thrown up once), ARTHRALGIA (Joint Pain), HEADACHE (Headache) and FATIGUE (Exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Skin burning sensation, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site vesicles
Clinical narrative: Blistered; "looks like someone burned her"; Red/brown area; Swollen; Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     NO medical history information was reported.  Concomitant products included LISINOPRIL, POTASSIUM and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful). At the time of the report, VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received treatment including Ice Pack. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     NO medical history information was reported.  Concomitant products included LISINOPRIL, POTASSIUM and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful). At the time of the report, VACCINATION SITE VESICLES (Blistered), SKIN BURNING SENSATION ("looks like someone burned her"), VACCINATION SITE ERYTHEMA (Red/brown area), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received treatment including Ice Pack.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 104.5 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 104.5 degrees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 104.5 degrees). At the time of the report, PYREXIA (fever of 104.5 degrees) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.5 (abnormal) 104.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: swollen, her shoulder down to the elbow in the right arm; muscle in her arm is still inflamed and painful; muscle in her arm is still inflamed and painful; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful), INJECTION SITE PAIN (muscle in her arm is still inflamed and painful) and INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful) and INJECTION SITE PAIN (muscle in her arm is still inflamed and painful). On an unknown date, the patient experienced INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm). At the time of the report, INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful), INJECTION SITE PAIN (muscle in her arm is still inflamed and painful) and INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No specific follow-up information recorded.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Tooth extraction, Tooth infection
Clinical narrative: tooth infection; Tooth extraction; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (tooth infection) and TOOTH EXTRACTION (Tooth extraction) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (MAXZIDE), AMLODIPINE BESILATE (NORVASC), MONTELUKAST SODIUM (SINGULAIR), FAMOTIDINE (PEPCID AC) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (tooth infection) and TOOTH EXTRACTION (Tooth extraction). The patient was treated with PENICILLIN NOS (PENICILLIN [PENICILLIN NOS]) for Adverse event, at a dose of UNK dosage form. At the time of the report, TOOTH INFECTION (tooth infection) and TOOTH EXTRACTION (Tooth extraction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Urticaria
Clinical narrative: swollen lips; Hives broke on her arms; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives broke on her arms) and LIP SWELLING (swollen lips) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced URTICARIA (Hives broke on her arms). On 28-Feb-2021, the patient experienced LIP SWELLING (swollen lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at a dose of UNK dosage form; PREDNISONE for Swollen lips, at a dose of UNK dosage form and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Swollen lips, at a dose of UNK dosage form. On 05-Mar-2021, URTICARIA (Hives broke on her arms) and LIP SWELLING (swollen lips) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. On 27-Feb-2021, the patient was given steroids as a corrective treatment. All the episodes got worst at night. It all lasted for 7 days. I was thought that it's partly due to the vaccine because her doctor told her that other patients had it due to the vaccine. Benadrly used to help her a lot with allergies.
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout flareup in the left heel; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of GOUT (gout flareup in the left heel) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Gout. Concomitant products included METHYLPREDNISOLONE for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GOUT (gout flareup in the left heel). The patient was treated with METHYLPREDNISOLONE for Adverse event, at a dose of 4 mg. At the time of the report, GOUT (gout flareup in the left heel) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Vaccination site pain
Clinical narrative: Coldness in right side mainly in the hand; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Coldness in right side mainly in the hand) and VACCINATION SITE PAIN (Pain in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (Coldness in right side mainly in the hand) and VACCINATION SITE PAIN (Pain in arm). At the time of the report, PERIPHERAL COLDNESS (Coldness in right side mainly in the hand) and VACCINATION SITE PAIN (Pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Illness, Injection site pain
Clinical narrative: very very sick; no appetite; achy; very fatigued; arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful); fever; shaking chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued) and INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills). On 08-Mar-2021, ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills) had resolved.            No information regarding corrective treatment was reported by the patient.    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: NNI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: very very sick; no appetite; achy; very fatigued; arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful); fever; shaking chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued) and INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills). On 08-Mar-2021, ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills) had resolved.            No information regarding corrective treatment was reported by the patient.    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: NNI
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: sugars went up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (sugars went up) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M208) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Disease Crohns, COPD and Hard of hearing.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (sugars went up). At the time of the report, BLOOD GLUCOSE INCREASED (sugars went up) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. The patient continued to take regular medications.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of injection site warmth (hot), injection site pain (hurts really bad), injection site swelling (swollen) and injection site erythema (pretty red) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 002A21A) for COVID-19 immunization. No medical history reported. On Feb 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced injection site warmth (hot), injection site pain (hurts really bad), injection site swelling (swollen) and injection site erythema (pretty red). At the time of the report, injection site warmth (hot), injection site pain (hurts really bad), injection site swelling (swollen) and injection site erythema (pretty red): unresolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medications reported. No information regarding corrective treatment reported.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Dysgeusia, Feeling abnormal, Hypoaesthesia
Clinical narrative: did not feel so good; like low blood sugar; he whole jaw felt numb (like she had gone to the dentist); metal taste in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel so good), BLOOD GLUCOSE DECREASED (like low blood sugar), HYPOAESTHESIA (he whole jaw felt numb (like she had gone to the dentist)) and DYSGEUSIA (metal taste in her mouth) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FEELING ABNORMAL (did not feel so good), BLOOD GLUCOSE DECREASED (like low blood sugar), HYPOAESTHESIA (he whole jaw felt numb (like she had gone to the dentist)) and DYSGEUSIA (metal taste in her mouth). On 12-Feb-2021, FEELING ABNORMAL (did not feel so good), BLOOD GLUCOSE DECREASED (like low blood sugar), HYPOAESTHESIA (he whole jaw felt numb (like she had gone to the dentist)) and DYSGEUSIA (metal taste in her mouth) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Rash, Urticaria
Clinical narrative: Hive; Swelling of the throat; Rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hive), PHARYNGEAL SWELLING (Swelling of the throat) and RASH (Rash) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced URTICARIA (Hive), PHARYNGEAL SWELLING (Swelling of the throat) and RASH (Rash). At the time of the report, URTICARIA (Hive), PHARYNGEAL SWELLING (Swelling of the throat) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain on the Injection Site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain on the Injection Site). On 28-Feb-2021, VACCINATION SITE PAIN (Pain on the Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication nor treatment provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rash started on both upper arms; slight itchy (rash); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036L20A) for COVID-19 vaccination.     no medical history provided.  Concomitant products included AMLODIPINE, APIXABAN (ELIQUIS), METOPROLOL SUCCINATE (TOPROL XL), ATORVASTATIN CALCIUM (LIPITOR) and GLYCERYL TRINITRATE (NITROL [GLYCERYL TRINITRATE]) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)). The patient was treated with TRIAMCINOLONE for Itching, at a dose of 1 %. At the time of the report, RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient felling temporarily better.   This case was linked to MOD-2021-225442 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness of arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness of arm). At the time of the report, VACCINATION SITE PAIN (Soreness of arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that she had taken vaccine at Hospital. No concomitant medication nor treatment provided.